Tandem Diabetes Care General and Administrative Expenses 2011-2026 | TNDM

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Tandem Diabetes Care

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
445 M	390 M	353 M	336 M	262 M	205 M	166 M	105 M	86.4 M	82.8 M	78.6 M	75.1 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
445 M	75.1 M	215 M

Quarterly General and Administrative Expenses Tandem Diabetes Care

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
108 M	110 M	114 M	-	99.6 M	94.2 M	90.1 M	-	79.3 M	97.6 M	89.8 M	-	84.1 M	80.6 M	73.3 M	-	64.9 M	66.5 M	58.6 M	-	50.2 M	50.4 M	49.7 M	-	44.6 M	40.6 M	35 M	-	29.5 M	22.6 M	20.9 M	-	20.1 M	22.1 M	22.8 M	-	20.7 M	21.1 M	22 M	-	19.1 M	19.6 M	19.4 M	-	18.9 M	18.1 M	18 M	-	12 M	11.3 M	6.88 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
114 M	6.88 M	49.4 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Aethlon Medical AEMD	3.24 M	$ 2.2	4.27 %	$ 3.43 M	USA
AdaptHealth Corp. AHCO	382 M	$ 10.61	1.82 %	$ 1.43 B	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	14.1 M	-	-26.83 %	$ 2.62 M	USA
Cognyte Software Ltd. CGNT	163 M	$ 8.42	0.48 %	$ 605 M	Israel
CONMED Corporation CNMD	132 M	$ 37.08	-0.88 %	$ 1.15 B	USA
Butterfly Network BFLY	39.8 M	$ 4.18	6.78 %	$ 885 M	USA
Alphatec Holdings ATEC	499 M	$ 12.88	2.22 %	$ 1.93 B	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Aziyo Biologics AZYO	15.1 M	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
EDAP TMS S.A. EDAP	5.9 M	$ 4.06	2.53 %	$ 151 M	France
BIOLASE BIOL	10.2 M	-	-13.19 %	$ 166 K	USA
Boston Scientific Corporation BSX	6.89 B	$ 71.68	2.71 %	$ 106 B	USA
Establishment Labs Holdings ESTA	165 M	$ 64.92	2.27 %	$ 1.92 B	Costa-rica
Conformis CFMS	28.8 M	-	-	$ 16.4 M	USA
Cytosorbents Corporation CTSO	35 M	$ 0.69	6.49 %	$ 37.6 M	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
Cutera CUTR	63.3 M	-	-10.19 %	$ 1.99 M	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
Dynatronics Corporation DYNT	8.46 M	-	14.99 %	$ 929 K	USA
ClearPoint Neuro CLPT	12 M	$ 11.21	1.63 %	$ 303 M	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
IRIDEX Corporation IRIX	8.75 M	$ 1.33	-0.38 %	$ 21.5 M	USA
Soliton, Inc. SOLY	8.46 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	18 M	-	-	$ 462 M	USA
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
FONAR Corporation FONR	23.5 M	$ 18.43	0.05 %	$ 121 M	USA
Helius Medical Technologies HSDT	9.27 M	$ 2.18	-0.46 %	$ 1.33 M	USA
GBS GBS	8.88 M	-	-0.57 %	$ 7.12 M	USA
InMode Ltd. INMD	8.41 M	$ 13.55	0.86 %	$ 876 M	Israel
LivaNova PLC LIVN	549 M	$ 62.74	2.12 %	$ 3.42 B	Britain
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
MiMedx Group MDXG	56.5 M	$ 4.43	0.57 %	$ 655 M	USA
Abbott Laboratories ABT	12.3 B	$ 111.47	1.38 %	$ 194 B	USA
Delcath Systems DCTH	43.5 M	$ 9.88	0.71 %	$ 354 M	USA
Bio-Rad Laboratories BIO	814 M	$ 268.82	2.9 %	$ 7.58 B	USA
Nano-X Imaging Ltd. NNOX	22.5 M	$ 2.61	0.58 %	$ 153 M	Israel
Integra LifeSciences Holdings Corporation IART	717 M	$ 9.22	2.33 %	$ 710 M	USA
AxoGen AXGN	44.6 M	$ 32.91	0.21 %	$ 1.52 B	USA
Align Technology ALGN	1.76 B	$ 177.63	4.83 %	$ 13.3 B	USA
Bruker Corporation BRKR	894 M	$ 34.0	3.79 %	$ 5.07 K	USA
BioSig Technologies BSGM	11.6 M	-	37.08 %	$ 85.7 M	USA
Apyx Medical Corporation APYX	15.8 M	$ 3.84	4.5 %	$ 158 M	USA
OrthoPediatrics Corp. KIDS	120 M	$ 17.34	1.34 %	$ 407 M	USA